These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 7673105)

  • 41. Sigma receptor-induced heavy drinking in rats: Modulation by the opioid receptor system.
    Valenza M; Blasio A; DiLeo A; Cottone P; Sabino V
    Pharmacol Biochem Behav; 2020 May; 192():172914. PubMed ID: 32205151
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel delta opioid receptor antagonist, SoRI-9409, produces a selective and long-lasting decrease in ethanol consumption in heavy-drinking rats.
    Nielsen CK; Simms JA; Pierson HB; Li R; Saini SK; Ananthan S; Bartlett SE
    Biol Psychiatry; 2008 Dec; 64(11):974-81. PubMed ID: 18774553
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Naltrexone effects on ethanol drinking acquisition and on established ethanol consumption in C57BL/6J mice.
    Phillips TJ; Wenger CD; Dorow JD
    Alcohol Clin Exp Res; 1997 Jun; 21(4):691-702. PubMed ID: 9194926
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of opiate antagonist treatment on the alcohol deprivation effect in long-term ethanol-experienced rats.
    Hölter SM; Spanagel R
    Psychopharmacology (Berl); 1999 Aug; 145(4):360-9. PubMed ID: 10460312
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interactions between cannabinoid and opioid receptor systems in the mediation of ethanol effects.
    Manzanares J; Ortiz S; Oliva JM; Pérez-Rial S; Palomo T
    Alcohol Alcohol; 2005; 40(1):25-34. PubMed ID: 15550451
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Delta-opioid receptor antagonism leads to excessive ethanol consumption in mice with enhanced activity of the endogenous opioid system.
    Poznanski P; Lesniak A; Korostynski M; Szklarczyk K; Lazarczyk M; Religa P; Bujalska-Zadrozny M; Sadowski B; Sacharczuk M
    Neuropharmacology; 2017 May; 118():90-101. PubMed ID: 28322978
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interactions of narcotics, narcotic antagonists, and ethanol during acute, chronic, and withdrawal states.
    Ho AK; Chen RC
    Ann N Y Acad Sci; 1976; 281():297-310. PubMed ID: 1071365
    [No Abstract]   [Full Text] [Related]  

  • 48. Effects of opiate antagonists and their quaternary derivatives on heroin self-administration in the rat.
    Koob GF; Pettit HO; Ettenberg A; Bloom FE
    J Pharmacol Exp Ther; 1984 May; 229(2):481-6. PubMed ID: 6716270
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drugs to decrease alcohol drinking.
    Sinclair JD
    Ann Med; 1990; 22(5):357-62. PubMed ID: 2291844
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combined low dose treatment with opioid and cannabinoid receptor antagonists synergistically reduces the motivation to consume alcohol in rats.
    Gallate JE; Mallet PE; McGregor IS
    Psychopharmacology (Berl); 2004 Apr; 173(1-2):210-6. PubMed ID: 14663553
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Opioid antagonists: structure activity relationships.
    Zimmerman DM; Leander JD
    NIDA Res Monogr; 1990; 96():50-60. PubMed ID: 2172827
    [No Abstract]   [Full Text] [Related]  

  • 52. Supersensitivity to the behavioral effects of opiate antagonists [proceedings].
    Spealman RD; Kelleher RT; Morse WH; Goldberg SR
    Psychopharmacol Bull; 1981 Jan; 17(1):54-6. PubMed ID: 7232659
    [No Abstract]   [Full Text] [Related]  

  • 53. [Opiates and their antagonists].
    Langwiński R
    Pol Tyg Lek; 1983 Dec 19-26; 38(51-52):1625-9. PubMed ID: 6089154
    [No Abstract]   [Full Text] [Related]  

  • 54. Low-dose prazosin alone and in combination with propranolol or naltrexone: effects on ethanol and sucrose seeking and self-administration in the P rat.
    Verplaetse TL; Czachowski CL
    Psychopharmacology (Berl); 2015 Aug; 232(15):2647-57. PubMed ID: 25743758
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reduction of alcohol drinking and upregulation of opioid receptors by oral naltrexone in AA rats.
    Parkes H; Sinclair JD
    Alcohol; 2000 Jul; 21(3):215-21. PubMed ID: 11091024
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chronic lithium administration alters the interaction between opiate antagonists and opiate receptors in vivo.
    Amir S; Simantov R
    Neuropharmacology; 1981 Jun; 20(6):587-91. PubMed ID: 6264340
    [No Abstract]   [Full Text] [Related]  

  • 57. [Receptor occupation and pharmacological activity as demonstrated on opiates (author's transl)].
    Herz A; Höllt V
    Arzneimittelforschung; 1977; 27(96):1865-7. PubMed ID: 200250
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of opiate antagonists and their quaternary analogues on nucleus accumbens self-stimulation.
    Trujillo KA; Belluzzi JD; Stein L
    Behav Brain Res; 1989 Jun; 33(2):181-8. PubMed ID: 2548531
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selectivity of opioid agonists and antagonists for the various opioid receptor types.
    Takemori AE; Portoghese PS
    Psychopharmacol Bull; 1985; 21(3):464-5. PubMed ID: 2994158
    [No Abstract]   [Full Text] [Related]  

  • 60. Tetrahydroisoquinoline and opioid substrates of alcohol actions.
    Altshuler HL; Shippenberg TS
    Prog Clin Biol Res; 1982; 90():329-44. PubMed ID: 7202207
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.